mazindol has been researched along with Constipation in 2 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Constipation: Infrequent or difficult evacuation of FECES. These symptoms are associated with a variety of causes, including low DIETARY FIBER intake, emotional or nervous disturbances, systemic and structural disorders, drug-induced aggravation, and infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delitala, G | 1 |
| Alagna, S | 1 |
| Masala, A | 1 |
| Sedgwick, JP | 1 |
1 trial available for mazindol and Constipation
| Article | Year |
|---|---|
Maziniol in the treatment of obesity.
Topics: Body Weight; Clinical Trials as Topic; Constipation; Humans; Indoles; Mazindol; Obesity; Placebos; S | 1975 |
1 other study available for mazindol and Constipation
| Article | Year |
|---|---|
[Mazindol (AN-448): a new non-amphetamine anorectic in the treatment of exogenous obesity].
Topics: Adolescent; Adult; Child; Constipation; Drug Evaluation; Female; Humans; Indoles; Male; Mazindol; Mi | 1977 |